Anti-EMMPRIN monoclonal antibody as a novel agent for therapy of head and neck cancer

Clinical Cancer Research

Volumn 15, Issue 12, 2009, Pages 4058-4065

  Dean, Nichole R ^a   Newman, J Robert ^a   Helman, Emily E ^a   Zhang, Wenyue ^a   Safavy, Seena ^a   Weeks, D M ^a   Cunningham, Mark ^c   Snyder, Linda A ^d   Tang, Yi ^d   Yan, Li ^d   McNally, Lacey R ^b   Buchsbaum, Donald J ^b   Rosenthal, Eben L ^a,e  

^a Kentucky   (United States)

^b The University of Alabama at Birmingham   (United States)

^c Centocor   (United States)

^d Oncology Department   (United States)

^e Division of Otolaryngology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD147 ANTIGEN; CNTO 3899; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; KI 67 ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY EMMPRIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; COLLAGEN DEGRADATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FIBROBLAST; GENETIC TRANSFECTION; HEAD AND NECK CANCER; IMMUNOHISTOCHEMISTRY; MOLECULAR THERAPY; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA; TUMOR CELL; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD147; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOKINES; FEMALE; FIBROBLASTS; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOLOGIC FACTORS; MICE; MICE, SCID; RNA, SMALL INTERFERING; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 67449152476     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-0212     Document Type: Article

References (33)

1. Leon X, Quer M, Orus C, del Prado Venegas M. Can cure be achieved in patients with head and neck carcinomas? The problem of second neoplasm. Expert Rev Anticancer Ther 2001;1:125-133 (Pubitemid 34679402)
2. Casiglia J,Woo SB. A comprehensive review of oral cancer. Gen Dent 2001;49:72-82.
3. McCawley LJ, Crawford HC, King LE, Jr., Mudgett J, Matrisian LM. A protective role for matrix metalloproteinase-3 in squamous cell carcinoma. Cancer Res 2004;64:6965-6972 (Pubitemid 39331006)
4. Elenbaas B, Weinberg RA. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res 2001;264:169-184 (Pubitemid 32989090)
5. Seljelid R, Jozefowski S, Sveinbjornsson B. Tumor stroma. Anticancer Res 1999;19:4809-4822 (Pubitemid 30093489)
6. Biswas C, ZhangY, DeCastro R, et al. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 1995;55:434-439
7. Riethdorf S, Reimers N, Assmann V, et al. High incidence of EMMPRIN expression in human tumors. Int JCancer 2006;119:1800-1810 (Pubitemid 44356836)
8. Bordador LC, Li X,Toole B, et al. Expression of emmprin by oral squamous cell carcinoma. Int J Cancer 2000;85:347-352 (Pubitemid 30030407)
9. Rosenthal EL, Shreenivas S, Peters GE, Grizzle WE, Desmond R, Gladson CL. Expression of extracellular matrix metalloprotease inducer in laryngeal squamous cell carcinoma. Laryngoscope 2003;113:1406-1410 (Pubitemid 36944687)
10. Sameshima T, Nabeshima K, Toole BP, et al. Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts. Cancer Lett 2000;157:177-184 (Pubitemid 30629029)
11. Kanekura T, Chen X, Kanzaki T. Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts. Int J Cancer 2002;99:520-528 (Pubitemid 34461604)
12. Tang Y, Nakada MT, Kesavan P, et al. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases. Cancer Res 2005;65:3193-3199 (Pubitemid 40524601)
13. Rosenthal EL, Vidrine DM, Zhang W. Extracellular matrix metalloprotease inducer stimulates fibroblast-mediated tumor growth in vivo. Laryngoscope 2006;116:1086-1092 (Pubitemid 44334750)
14. Zhang W, Matrisian LM, Holmeck K, Vick CC, Rosenthal EL. Fibroblast-derived MT1-MMP promotes tumor progression in vitro and in vivo. BMC Cancer 2006;6:52. (Pubitemid 46277066)
15. Caudroy S, Polette M, Nawrocki-Raby B, et al. EMMPRIN-mediated MMP regulation in tumor and endothelial cells. Clin Exp Metastasis 2002;19:697-702. (Pubitemid 36092265)
16. Braundmeier AG, Fazleabas AT, Lessey BA, Guo H, Toole BP, Nowak RA. Extracellular matrix metalloproteinase inducer regulates metalloproteinases in human uterine endometrium. J Clin Endocrinol Metab 2006;91:2358-2365 (Pubitemid 43855028)
17. Dalberg K, Eriksson E, Enberg U, Kjellman M, Backdahl M. Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer. World J Surg 2000;24:334-340 (Pubitemid 30117763)
18. Zucker S, Hymowitz M, Rollo EE, et al. Tumorigenic potential of extracellular matrix metalloproteinase inducer. Am J Pathol 2001;158:1921-1928 (Pubitemid 32545174)
19. Ju X-Z, Yang J-M, Zhou X-Y, Li Z-T, Wu X-H. EMMPRIN expression as a prognostic factor in radiotherapy of cervical cancer. Clin Cancer Res 2008;14:494-501. (Pubitemid 351226118)
20. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006;354:567-578 (Pubitemid 43209104)
21. Feng FY, Lopez CA, Normolle DP, et al. Effect of epidermal growth factor receptor inhibitor class in the treatment of head and neck cancer with concurrent radiochemotherapy in vivo. Clin Cancer Res 2007;13:2512-2518 (Pubitemid 46698604)
22. Newman JR, Bohannon IA, ZhangW, Skipper JB, GrizzleWE, Rosenthal EL. Modulation of tumor cell growth in vivo by extracellular matrix metalloprotease inducer. Arch Otolaryngol Head Neck Surg 2008;134:1218-1224
23. Tang Y, Kesavan P, Nakada MT, Yan L. Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. Mol Cancer Res 2004;2:73-80. (Pubitemid 38250423)
24. Saleh MN, Raisch KP, Stackhouse MA, et al. Combined modality therapy of A431 human epidermoid cancer using anti-EGFR antibody C225 and radiation. Cancer Biother Radiopharm 1999;14:451-463 (Pubitemid 30029793)
25. Skipper JB, McNally LR, Rosenthal EL, Wang W, Buchsbaum DJ. In vivo efficacy of marimastat and chemoradiation in head and neck cancer xenografts. ORL J Otorhinolaryngol Relat Spec 2009;71:1-5.
26. Yang ES, Murphy BM, Chung CH, et al. Evolution of clinical trials in head and neck cancer. Crit Rev Oncol Hematol 2008.
27. Huang SM, Bock JM, Harari PM. Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck. Cancer Res 1999;59:1935-1940 (Pubitemid 29186168)
28. Rosenthal EL, Zhang W, Talbert M, Raisch KP, Peters GE. Extracellular matrix metalloprotease inducer-expressing head and neck squamous cell carcinoma cells promote fibroblast-mediated type I collagen degradation in vitro. Mol Cancer Res 2005;3:195-202. (Pubitemid 40525330)
29. Knerer B, Hulla W, Martinek H, Formanek M, Temmel A, Kornfehl J. IL-1 and TNF-alpha but no IL-2 expression is found in squamous cell carcinomas of the head and neck by RT-PCR. Acta Otolaryngol 1996;116:132-136 (Pubitemid 26040050)
30. Thomas GR, Chen Z, Leukinova E, Van Waes C, Wen J. Cytokines IL-1 alpha, IL-6, and GM-CSF constitutively secreted by oral squamous carcinoma induce down-regulation of CD80 costimulatory molecule expression: restoration by interferon gamma. Cancer Immunol Immunother 2004;53:33-40.
31. Bancroft CC, Chen Z, Dong G, et al. Coexpression of proangiogenic factors IL-8 and VEGF by human head and necks quamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways. Clin Cancer Res 2001;7:435-442 (Pubitemid 32183050)
32. Chen Z, Malhotra PS,Thomas GR, et al. Expression of proinflammatory and proangiogenic cytokines in patients with head and neckca ncer. Clin Cancer Res 1999;5:1369-1379 (Pubitemid 29282941)
33. Saijo Y, Tanaka M, Miki M, et al. Proinflammatory cytokine IL-1 beta promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors: in vivo analysis of tumor-stromal interaction. J Immunol 2002;169:469-475 (Pubitemid 34686169)